2 results match your criteria: "Riga East Clinical University Hospital Latvian Oncology Center[Affiliation]"
Prognostic factors in patients with uterine sarcoma: the SARCUT study.
Int J Gynecol Cancer
June 2023
Gynecologic Oncology Department, Tepecik Training and Research Hospital Clinics, Konak, Izmir, Turkey.
Objective: Uterine sarcomas are a rare and heterogeneous group of malignancies that include different histological sub-types. The aim of this study was to identify and evaluate the impact of the different prognostic factors on overall survival and disease-free survival of patients with uterine sarcoma.
Methods: This international multicenter retrospective study included 683 patients diagnosed with uterine sarcoma at 46 different institutions between January 2001 and December 2007.
Prognostic factors in patients with vulvar cancer: the VULCAN study.
Int J Gynecol Cancer
September 2020
Gynecologic Oncology Department, Riga East Clinical University Hospital Latvian Oncology Center, Riga, Latvia.
Objective: This study aimed to analyze the prognostic factors for overall and progression-free survival in patients with vulvar cancer.
Methods: This international, multicenter, retrospective study included 2453 patients diagnosed with vulvar cancer at 100 different institutions. Inclusion criteria were institutional review board approval from each collaborating center, pathologic diagnosis of invasive carcinoma of the vulva, and primary treatment performed at the participating center.